Ratings Vital Healthcare Property Trust

Equities

VHP

NZCHPE0001S4

End-of-day quote New Zealand S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
2.185 ^NZD	+1.16%		+0.23%	-1.13%

Mar. 13	Vital Healthcare Property Trust Declares DRP Strike Price for Q2 Dividend	MT
Feb. 15	Vital Healthcare Property Trust Widens Net Loss in Fiscal H1	MT

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
The company has a poor ESG score according to Refinitiv, which ranks companies by sector.

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The company appears to be poorly valued given its net asset value.
The company is one of the best yield companies with high dividend expectations.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Based on current prices, the company has particularly high valuation levels.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

	1st Jan change	Capi.	ESG Refinitiv
VITAL HEALTHCARE PROPERTY TRUST	-1.13%	868M	D+
WELLTOWER INC.	+4.76%	56.3B	A-
VENTAS, INC.	-11.86%	17.83B	A-
HEALTHPEAK PROPERTIES, INC.	-5.81%	13.1B	A
HEALTHCARE REALTY TRUST INCORPORATED	-17.41%	5.43B	B-
CARETRUST REIT, INC.	+10.08%	3.34B	C-
SABRA HEALTH CARE REIT, INC.	-2.84%	3.22B	C+
AEDIFICA SA	-5.50%	3.06B	B+
MEDICAL PROPERTIES TRUST, INC.	-4.28%	2.79B	C
NATIONAL HEALTH INVESTORS, INC.	+13.84%	2.74B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes